Skip to main content

Advertisement

Log in

18F-FDG-PET/CT: an accurate method to assess the activity of Takayasu’s arteritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of the study is to investigate the value of 18F-fluorodeoxyglucose–positron emission tomography/computed tomography (18F-FDG-PET/CT) for assessment of the activity of Takayasu’s arteritis (TA) and the correlation between acute-phase reactive proteins (ARPs) and standard uptake value (SUV). Analyses of the clinical characteristics and 42 18F-FDG-PET/CT scans in 39 TA patients were undertaken. The degree of FDG uptake in the blood vessel walls was assessed quantitatively by SUV. TA activity was analyzed by physician global assessment (PGA). Clinical and 18F-FDG-PET/CT characteristics were compared between patients with clinically active and clinically inactive TA. Maximum SUV (SUVmax), mean SUV (SUVmean), and SUV ratio (SUVratio) were significantly higher in the clinically active group than in the clinically inactive group (3.63 ± 1.96 vs. 1.82 ± 0.43, p = 0.007; 2.07 ± 0.71 vs. 1.43 ± 0.32, p = 0.009; 2.08 ± 1.17 vs. 0.95 ± 0.19, p = 0.000). Analyses of receiver operating characteristic (ROC) curves revealed a cutoff value of SUVmax of 2.21, with sensitivity and specificity of 86.2 and 90.0%, respectively, for clinically active TA. The SUVratio cutoff was 1.27 with a sensitivity and specificity of 79.3 and 100.0%, respectively. SUVratio was slightly superior to SUVmax and ARPs in the area under the curve (AUC) comparison. SUVmax and SUVratio showed a significant increasing trend with increasing US National Institutes of Health (NIH) score and levels of ARPs, interleukin-6, and serum amyloid-A protein. 18F-FDG-PET/CT is a promising non-invasive, quantitative measurement with high sensitivity and specificity for determining TA activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer HT, Seyahi E, Akar S, Onen F, Cefle A, Aydin SZ, Yilmaz N, Onat AM, Cobankara V, Tunc E, Ozturk MA, Fresko I, Karaaslan Y, Akkoc N, Yucel AE, Kiraz S, Keser G, Inanc M, Direskeneli H (2009) Takayasu’s arteritis in Turkey—clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(1 Suppl 52):S59–S64

    PubMed  CAS  Google Scholar 

  2. Mason JC (2010) Takayasu arteritis—advances in diagnosis and management. Nat Rev Rheumatol 6(7):406–415. https://doi.org/10.1038/nrrheum.2010.82

    Article  PubMed  Google Scholar 

  3. Alibaz-Oner F, Aydin SZ, Direskeneli H (2013) Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis. Clin Rheumatol 32(5):541–546. https://doi.org/10.1007/s10067-012-2149-3

    Article  PubMed  Google Scholar 

  4. Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, de Groot K, Guillevin L, Hatemi G, Hauser T, Jayne D, Jennette C, Kallenberg CG, Kobayashi S, Little MA, Mahr A, McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani C, Savage C, Scott DG, Segelmark M, Specks U, Sunderkoetter C, Suzuki K, Tesar V, Wiik A, Yazici H, Luqmani R (2010) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 69(10):1744–1750. https://doi.org/10.1136/ard.2009.119032

    Article  PubMed  Google Scholar 

  5. Yadav MK (2007) Takayasu arteritis: clinical and CT-angiography profile of 25 patients and a brief review of literature. Indian Heart J 59(6):468–474

    PubMed  Google Scholar 

  6. Jiang L, Li D, Yan F, Dai X, Li Y, Ma L (2012) Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol 155(2):262–267. https://doi.org/10.1016/j.ijcard.2010.10.002

    Article  PubMed  Google Scholar 

  7. Germano G, Monti S, Ponte C, Possemato N, Caporali R, Salvarani C, Macchioni P, Pipitone N (2017) The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol 103(1):194–198

    Google Scholar 

  8. Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, Hillengass J, Engelhardt M, Usmani SZ, Vesole DH, San-Miguel J, Kumar SK, Richardson PG, Mikhael JR, da Costa FL, Dimopoulos MA, Zingaretti C, Abildgaard N, Goldschmidt H, Orlowski RZ, Chng WJ, Einsele H, Lonial S, Barlogie B, Anderson KC, Rajkumar SV, Durie BGM, Zamagni E (2017) Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol 18(4):e206–e217. https://doi.org/10.1016/S1470-2045(17)30189-4

    Article  PubMed  Google Scholar 

  9. Gallamini A, Borra A (2017) FDG-PET scan: a new paradigm for follicular lymphoma management. Mediterranean J Hematol Infect Dis 9(1):e2017029. https://doi.org/10.4084/MJHID.2017.029

    Article  Google Scholar 

  10. Harrison DJ, Parisi MT, Shulkin BL (2017) The role of 18F-FDG-PET/CT in pediatric sarcoma. Semin Nucl Med 47(3):229–241. https://doi.org/10.1053/j.semnuclmed.2016.12.004

    Article  PubMed  Google Scholar 

  11. Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, Sato N, Konishi J (2002) Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med : Off Publ Soc Nucl Med 43(5):658–663

    CAS  Google Scholar 

  12. Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, Numano F (2005) Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med : Off Publ Soc Nucl Med 46(6):917–922

    Google Scholar 

  13. Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J, Hirao K, Isobe M (2012) Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 5(4):422–429. https://doi.org/10.1016/j.jcmg.2012.01.013

    Article  PubMed  Google Scholar 

  14. Arnaud L, Haroche J, Malek Z, Archambaud F, Gambotti L, Grimon G, Kas A, Costedoat-Chalumeau N, Cacoub P, Toledano D, Cluzel P, Piette JC, Amoura Z (2009) Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 60(4):1193–1200. https://doi.org/10.1002/art.24416

    Article  PubMed  Google Scholar 

  15. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134

    Article  PubMed  CAS  Google Scholar 

  16. Li D, Lin J, Yan F (2011) Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. J Comput Assist Tomogr 35(4):468–474. https://doi.org/10.1097/RCT.0b013e318222d698

    Article  PubMed  Google Scholar 

  17. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929. https://doi.org/10.7326/0003-4819-120-11-199406010-00004

    Article  PubMed  CAS  Google Scholar 

  18. Zhou J, Li Y, Zhang Y, Liu G, Tan H, Hu Y, Xiao J, Shi H (2017) Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma. Oncotarget 8(14):23312–23321. https://doi.org/10.18632/oncotarget.15577

    Article  PubMed  PubMed Central  Google Scholar 

  19. Andrews J, Al-Nahhas A, Pennell DJ, Hossain MS, Davies KA, Haskard DO, Mason JC (2004) Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis. Ann Rheum Dis 63(8):995–1000. https://doi.org/10.1136/ard.2003.015701

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. de Leeuw K, Bijl M, Jager PL (2004) Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 22(6 Suppl 36):S21–S26

    PubMed  Google Scholar 

  21. Webb M, Chambers A, AL-N A, Mason JC, Maudlin L, Rahman L, Frank J (2004) The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31(5):627–634. https://doi.org/10.1007/s00259-003-1429-1

    Article  PubMed  Google Scholar 

  22. Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, Jeyaseelan L, Lawrence A, Bacon PA, Indian Rheumatology Vasculitis g (2013) Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology 52(10):1795–1801. https://doi.org/10.1093/rheumatology/ket128

    Article  PubMed  Google Scholar 

  23. Hoffman GS, Ahmed AE (1998) Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 66(Suppl 1):S191–S194 discussion S195

    Article  PubMed  Google Scholar 

  24. Ertay T, Sencan Eren M, Karaman M, Oktay G, Durak H (2017) 18F-FDG-PET/CT in initiation and progression of inflammation and infection. Mol Imaging and Radionuclide Ther 26(2):47–52. https://doi.org/10.4274/mirt.18291

    Article  Google Scholar 

  25. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU (2005) The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32(6):674–681. https://doi.org/10.1007/s00259-004-1757-9

    Article  PubMed  Google Scholar 

  26. Henes JC, Muller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, Kotter I (2008) [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 26(3 Suppl 49):S47–S52

    PubMed  CAS  Google Scholar 

  27. Lee SG, Ryu JS, Kim HO, JS O, Kim YG, Lee CK, Yoo B (2009) Evaluation of disease activity using F-18 FDG PET-CT in patients with Takayasu arteritis. Clin Nucl Med 34(11):749–752. https://doi.org/10.1097/RLU.0b013e3181b7db09

    Article  PubMed  Google Scholar 

  28. Lee KH, Cho A, Choi YJ, Lee SW, Ha YJ, Jung SJ, Park MC, Lee JD, Lee SK, Park YB (2012) The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis. Arthritis Rheum 64(3):866–875. https://doi.org/10.1002/art.33413

    Article  PubMed  Google Scholar 

  29. Karapolat I, Kalfa M, Keser G, Yalcin M, Inal V, Kumanlioglu K, Pirildar T, Aksu K (2013) Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu’s arteritis. Clin Exp Rheumatol 31(1 Suppl 75):S15–S21

    PubMed  CAS  Google Scholar 

  30. Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S (2014) F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol : Off Publ Am Soc Nucl Cardiol 21(5):993–1000. https://doi.org/10.1007/s12350-014-9910-8

    Article  Google Scholar 

  31. Sun Y, Ma L, Yan F, Liu H, Ding Y, Hou J, Jiang L (2012) MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu’s arteritis. Int J Cardiol 156(2):236–238. https://doi.org/10.1016/j.ijcard.2012.01.035

    Article  PubMed  Google Scholar 

  32. Kong X, Sun Y, Ma L, Chen H, Wei L, Wu W, Ji Z, Ma L, Zhang Z, Zhang Z, Zhao Z, Hou J, Dai S, Yang C, Jiang L (2016) The critical role of IL-6 in the pathogenesis of Takayasu arteritis. Clin Exp Rheumatol 34(3 Suppl 97):S21–S27

    PubMed  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (81571571).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lindi Jiang.

Ethics declarations

The study protocol was approved by the ethics committee of Fudan University (Shanghai, China). All patients provided written informed consent to participate in the study.

Disclosures

None.

Electronic supplementary material

Online Resource 1

(XLSX 15 kb)

Online Resource 2

(XLSX 11 kb)

Online Resource 3

(XLSX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Zhou, J., Sun, Y. et al. 18F-FDG-PET/CT: an accurate method to assess the activity of Takayasu’s arteritis. Clin Rheumatol 37, 1927–1935 (2018). https://doi.org/10.1007/s10067-017-3960-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3960-7

Keywords

Navigation